Skip to main content
. Author manuscript; available in PMC: 2010 Aug 18.
Published in final edited form as: J Neuroimmunol. 2009 Jul 24;213(1-2):123–130. doi: 10.1016/j.jneuroim.2009.05.014

Table 3.

CIS Patient Summary and Signature Score Predictions

Subject
No.a
Time
to LPb
MRI
Brain
Lesions
OCB CD19/
CD138c
CD19
VH4 biasd
CD138
VH4 biasd
Signature
Scoree
Prediction
based on
signature
score
Definite
MS
Time
to MS
Diagnosisf
CIS132 1 GD+ Yes 19/NA No NA 12.1 CDMS Clinical 18
CIS429 1 GD+ Yes 56/NA No NA 15.0 CDMS Clinical 3
CIS3-1 2 WML Yes 24/76 Yes Yes 15.5 CDMS MRI 3
ON3-3 4 GD+ Yes 39/13 No No 11.3 CDMS Clinical 3
ON3–5 1.75 GD+ Yes 35/44 Yes Yes 12.8 CDMS Clinical 2
ON4–7 3 Noneg Yes 17/20 No Yes 10.2 CDMS Clinical 5
ON4–8 1.5 WML Yes NA/18 NA Yes 9.6 CDMS Clinical 5
ON5-2 1 GD+ Yes 29/12 Yes Yes 7.9 CDMS Clinical 3

ON3-1 10 WML Yes 23/45 No No 6.4 No - NA
ON4–10 1.25 WML No 31/NA No NA 2.2 No - NA

ON3–4 1.5 Noneg No 28/NA No NA 11.3 CDMS - NA

Abbreviations in table: CIS, Clinically Isolated Syndrome; ON, Optic Neuritis; LP, lumbar puncture; GD, gadolinium enhancing lesion positive; WML, white matter lesions by T2; OCB, oligoclonal bands; CDMS, clinically definite MS; NA, not applicable

a

CIS132 and CIS429 were generated at UTSWMC; the remaining patient CSF B cell repertoires were generated at UCD.

b

months from first demyelinating event to LP

c

Values given are number of unique sequences in CD19 repertoire/CD138 repertoire; family usage can be found in (Bennett et al., 2008; Harp et al., 2007); CIS429 was a 62 y.o. male first presenting with optic neuritis and the repertoire had 2% VH1 usage, 0% VH2, 77% VH3, and 19% VH4.

d

Bias was considered significantly different from random frequency (Cook and Tomlinson, 1995) or expected frequency in HCPB (Brezinschek et al., 1997; Brezinschek et al., 1998; Dorner et al., 1997; Dorner et al., 1998a; Dorner et al., 1998b; Dorner et al., 1998c; Farner et al., 1999; Hansen et al., 2000; Monson et al., 2000). VH2 bias was also observed in CD19 repertoires from ON4–7, and CD138 repertoires from ON3-3, ON3–5 and ON4–7.

e

Signature score was calculated as outlined in materials and methods, and uses both CD19 and CD138 sequences. The average score among MS patients is 10.9 ±2.0.

f

months from first demyelinating event to MS diagnosis.

g

One spinal cord lesion was observed by T2 weighted MRI